Open access · CC-BY
via OpenAlex
Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution
Federica Francescangeli, Maria Laura De Angelis, Rachele Rossi, Adriano Cuccu, Alessandro Giuliani, Ruggero De Maria, Ann Zeuner
Cancer and Metastasis Reviews · 2023 · ▲ 68 citations
Abstract
The biological complexity of cancer represents a tremendous clinical challenge, resulting in the frequent failure of current treatment protocols. In the rapidly evolving scenario of a growing tumor, anticancer treatments impose a drastic perturbation not only to cancer cells but also to the tumor microenvironment, killing a portion of the cells and inducing a massive stress response in the survivors. Consequently, treatments can act as a double-edged sword by inducing a temporary response while laying the ground for therapy resistance and subsequent disease progression. Cancer cell dormancy (or quiescence) is a central theme in tumor evolution, being tightly linked to the tumor's ability to survive cytotoxic challenges, metastasize, and resist immune-mediated attack. Accordingly, quiescent cancer cells (QCCs) have been detected in virtually all the stages of tumor development. In recent years, an increasing number of studies have focused on the characterization of quiescent/therapy resistant cancer cells, unveiling QCCs core transcriptional programs, metabolic plasticity, and mechanisms of immune escape. At the same time, our partial understanding of tumor quiescence reflects the difficulty to identify stable QCCs biomarkers/therapeutic targets and to control cancer dormancy in clinical settings. This review focuses on recent discoveries in the interrelated fields of dormancy, stemness, and therapy resistance, discussing experimental evidences in the frame of a nonlinear dynamics approach, and exploring the possibility that tumor quiescence may represent not only a peril but also a potential therapeutic resource.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s10555-023-10092-4
- Canonical
- link ↗
- Fetched
- 2026-06-19 MST
Cite this
APA
Francescangeli, F., Angelis, M.L.D., Rossi, R., Cuccu, A., Giuliani, A., Maria, R.D., & Zeuner, A. (2023). Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution. <em>Cancer and Metastasis Reviews</em>. https://doi.org/10.1007/s10555-023-10092-4
Vancouver
Francescangeli F, Angelis MLD, Rossi R, Cuccu A, Giuliani A, Maria RD, et al. Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution. Cancer and Metastasis Reviews. 2023. doi:10.1007/s10555-023-10092-4.
BibTeX
@article{federica2023Dorman,
title = {Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution},
author = {Federica Francescangeli and Maria Laura De Angelis and Rachele Rossi and Adriano Cuccu and Alessandro Giuliani and Ruggero De Maria and Ann Zeuner},
journal = {Cancer and Metastasis Reviews},
year = {2023},
doi = {10.1007/s10555-023-10092-4},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Human Molecular Genetics 2017
Open access · OA
Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID
Cell Biology and Toxicology 2019
Open access · CC-BY
Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy
International Journal of Hematology 2014
Open access · OA
Cancer gene therapy using mesenchymal stem cells
Genes & Development 2010
Open access · OA
Molecular genetics of prostate cancer: new prospects for old challenges
Seminars in Cancer Biology 2022
Open access · CC-BY
Radiotherapy-induced remodeling of the tumor microenvironment by stromal cells
Nature 2023
Preprint · OA